Oireachtas Joint and Select Committees
Wednesday, 15 October 2025
Joint Oireachtas Committee on Health
Treatment of Rare Diseases: Discussion
2:00 am
Maria Byrne (Fine Gael)
On the orphan drugs that fail the HTA due to restrictive cost-effectiveness, is the Department considering a different valuation framework or just a threshold for these medicines?
No comments